This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should Vanguard S&P MidCap 400 Growth ETF (IVOG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOG
S&P Mid-Cap 400 Growth ETF (IVOG) Hits a New 52-Week High
by Sweta Jaiswal, FRM
This Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) has hit a new 52-week high. Are more gains in store?
Mid-Cap ETFs Outperforming to Start June
by Sweta Killa
Investors seeking to capitalize on strong fundamentals but worried about trade war should consider mid-cap stocks in the basket form.
Healthcare and Mid-Cap: 2 ETFs to Watch on Outsized Volume
by Sweta Killa
PTH and IVOG saw massive trading volumes in yesterday trading session.
Why Should You Buy Mid-Cap ETFs Now?
by Sweta Killa
Here are the strong reasons for the outperformance of the mid-cap ETFs.
Mid-Cap ETFs to Profit From Earnings Growth Amid Trade Woes
by Sweta Killa
Mid-cap ETFs are arguably safer and have the potential to move higher in turbulent times, especially if political issues or financial instability creeps into the picture.
Tax Reform: A Boon or Bane for Small-Cap ETFs?
by Sanghamitra Saha
Small-cap ETFs may be gaining on tax cut hopes but all is not rosy in the tax blueprint for the pint-sized stocks.